专利检索_ .动物乳杆菌专利检索_ .动物乳杆菌专利检索查询

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
1	Bacterial composition	US14587705	2014-12-31	US09278115B2	2016-03-08	Joseph F. Flint; Matthew Ryan Garner
A bacterial composition that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The composition is constituted of various combinations of the following four unique pathogen-inhibiting bacteria: (1) Lactobacillus animalis strain MB101; (2) Lactobacillus animalis strain MB102; (3) Enterococcus faecium strain MB505; and (4) Pediococcus acidilactici strain MB902. Each of the discovered bacteria is deposited with the American Type Culture Collection (ATCC) and respectively has an individual ATCC Accession Number.
2	COMPOSITION AND METHOD FOR EXTENDING SHELF LIFE OF LACTIC ACID BACTERIA	US15074826	2016-03-18	US20160270426A1	2016-09-22	Steven P. Lerner
Methods and compositions are disclosed for enhancing the shelf life of probiotic bacteria, such as lactic acid bacteria (LAB). In one particular formulation, oil, soybean meal and a silicon-containing compound are mixed with LAB to extend the shelf life of the LAB to about six months or longer at normal ambient temperature.
3	LACTIC ACID BACTERIUM AS PET DIETARY SUPPLEMENT	US14950230	2015-11-24	US20160143317A1	2016-05-26	Steven P. Lerner
Compositions and methods are disclosed for enhancing weight gain and feed efficiency in pets, such as dogs. The methods include administering to the pet a lactic acid producing bacterium (LAB) or combination of LABs as dietary supplements. The disclosed methods and compositions may also help reduce pathogen infection in dogs.
4	BACTERIAL COMPOSITION	US14587705	2014-12-31	US20150118204A1	2015-04-30	Joseph F. Flint; Matthew Ryan Garner
A bacterial composition that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The composition is constituted of various combinations of the following four unique pathogen-inhibiting bacteria: (1) Lactobacillus animalis strain MB101; (2) Lactobacillus animalis strain MB102; (3) Enterococcus faecium strain MB505; and (4) Pediococcus acidilactici strain MB902. Each of the discovered bacteria is deposited with the American Type Culture Collection (ATCC) and respectively has an individual ATCC Accession Number.
5	Use Of Lactic Acid Bacteria To Reduce Pathogens And As A Bio-Sanitizer	US14236542	2012-07-31	US20140341872A1	2014-11-20	Douglas R. Ware; Philip G. Crandall; Steven C. Ricke
Compositions and methods are disclosed for improving food safety. One or more lactic acid producing microorganisms are shown to inhibit pathogenic contaminations on food materials. The lactic acid producing microorganisms are capable of adhering to various surfaces and may serve as a bio-sanitizing agent (or bio-sanitizer). Lactic acid producing microorganisms or cell free extract of these microorganisms may be used in an effective and natural method to prevent L. monocytogenes infection in food products, as well as in food processing facilities and equipments.
6	COMPOSITIONS AND METHODS FOR INHIBITING PATHOGENIC GROWTH	US15288870	2016-10-07	US20170020935A1	2017-01-26	Bryan E. Garner; Douglas R. Ware
The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus animalis or one or a combination of a number of other probiotic bacteria to an animal. An alternative treatment method comprises administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus animalis in combination with a lactate utilizing bacterium such as Propionibacterium freudenreichii.
7	BACTERIAL COMPOSITION	US14575916	2014-12-18	US20150104418A1	2015-04-16	Joseph F. Flint; Matthew Ryan Garner
A bacterial composition that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The composition is constituted of various combinations of the following four unique pathogen-inhibiting bacteria: (1) Lactobacillus animalis strain MB101; (2) Lactobacillus animalis strain MB102; (3) Enterococcus faecium strain MB505; and (4) Pediococcus acidilactici strain MB902. Each of the discovered bacteria is deposited with the American Type Culture Collection (ATCC) and respectively has an individual ATCC Accession Number.
8	Composition And Methods For Inhibiting Pathogenic Growth	US14252569	2014-04-14	US20140286919A1	2014-09-25	Bryan E. Garner; Douglas R. Ware
The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus animalis or one or a combination of a number of other probiotic bacteria to an animal. An alternative treatment method comprises administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus animalis in combination with a lactate utilizing bacterium such as Propionibacterium freudenreichii.
9	BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA	US12993616	2009-05-21	US20110268842A1	2011-11-03	Elvira Garza Gonzalez; Francisco Javier Bosques Padilla; Sandra Naranjo Modad; Victor Manuel Moreno Campaña
A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on Apr. 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175.
10	BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA	EP09750794.1	2009-05-21	EP2305838B1	2015-01-28	GARZA GONZÁLEZ, Elvira; BOSQUES PADILLA, Francisco Javier; NARANJO MODAD, Sandra; MORENO CAMPAÑA, Víctor Manuel
A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on April 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175.
11	BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA	EP09750794	2009-05-21	EP2305838A4	2014-01-08	GARZA GONZALEZ ELVIRA; BOSQUES PADILLA FRANCISCO JAVIER; NARANJO MODAD SANDRA; MORENO CAMPANA VICTOR MANUEL
A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on April 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175.
12	BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA	EP09750794.1	2009-05-21	EP2305838A2	2011-04-06	GARZA GONZÁLEZ, Elvira; BOSQUES PADILLA, Francisco Javier; NARANJO MODAD, Sandra; MORENO CAMPAÑA, Víctor Manuel
A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on April 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175.
13	REDUCTION OF PATHOGEN IN PLANT MATERIALS USING LACTIC ACID PRODUCING MICROORGANISMS	PCT/US2011034617	2011-04-29	WO2011139904A3	2012-04-05	WARE DOUGLAS R; BRASHEARS MINDY
Improved compositions and methods are disclosed for improving food safety. More specifically, one or more lactic acid producing microorganisms are used for inhibiting pathogenic growth on plant materials before, during and/or after harvest. The disclosed methodology is particularly effective for leafy vegetables, such as spinach.
14	BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA	PCT/MX2009000046	2009-05-21	WO2009142472A2	2009-11-26	GARZA GONZALEZ ELVIRA; BOSQUES PADILLA FRANCISCO JAVIER; NARANJO MODAD SANDRA; MORENO CAMPANA VICTOR MANUEL
The invention relates to a bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml and 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. Said Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America under the Budapest Treaty, dated 23 April 2008 and identified with the ATCC number for patent PTA-9175.

该功能需要专业版企业版VIP权限，您可以：